Last Updated:2025/11/30
Researchers developed triabodies that can simultaneously bind three different antigens, offering a new strategy for targeted immunotherapy.
See correct answer
Researchers developed triabodies that can simultaneously bind three different antigens, offering a new strategy for targeted immunotherapy.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories(0)
Source Sentence
研究者たちは、3つの異なる抗原に同時に結合できるトリアボディ分子を開発し、標的化免疫療法の新たな戦略を提示しました。